NewslettersCancer Stem Cell NewsWDR5 Represents a Therapeutically Exploitable Target for Cancer Stem Cells in GlioblastomaBy Bob - February 8, 20230378In glioblastomas CSCs, WDR5 inhibitors blocked WRAD complex assembly and reduced H3K4 trimethylation and expression of genes involved in CSC-relevant oncogenic pathways.[Genes & Development]Abstract